Systemic sclerosis: An ultrasonographic study of skin and subcutaneous tissue in relation to clinical findings

Skin Research and Technology

Volumn 19, Issue 1, 2013, Pages

  Sedky, Manal Mohamed ^a   Fawzy, Samar Mohamed ^a   El Baki, Noha Abd ^a   El Eishi, Nermine Hamdi ^a   El Bohy, Abo El Magd Mohamed ^b  

^a CAIRO UNIVERSITY   (Egypt)

^b CAIRO UNIVERSITY   (Egypt)

Author keywords

Severity score; Skin score; Skin thickness; Subcutaneous fat thickness; Systemic sclerosis; Ultrasound

Indexed keywords

CLINICAL PARAMETERS; CONTROL SUBJECT; DIAGNOSTIC CRITERION; DISEASE SEVERITY; HEALTHY CONTROLS; HIGH FREQUENCY; HIGH FREQUENCY ULTRASOUNDS; NONINVASIVE TOOLS; SEVERITY SCORE; SKIN THICKNESS; SUBCUTANEOUS FAT THICKNESS; SUBCUTANEOUS TISSUES; SYSTEMIC SCLEROSIS; ULTRASOUND MEASUREMENT;

DIAGNOSIS; ULTRASONIC APPLICATIONS; ULTRASONICS;

TISSUE;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; ECHOGRAPHY; FEMALE; HUMAN; MALE; MODIFIED RODNAN SKIN SCORE; SCORING SYSTEM; SKIN; SKINFOLD THICKNESS; SUBCUTANEOUS TISSUE; SYSTEMIC SCLEROSIS;

ADOLESCENT; ADULT; AGED; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; SCLERODERMA, SYSTEMIC; SEVERITY OF ILLNESS INDEX; SKIN; SUBCUTANEOUS TISSUE; ULTRASONOGRAPHY; YOUNG ADULT;

EID: 84872132043     PISSN: 0909752X     EISSN: 16000846     Source Type: Journal    
DOI: 10.1111/j.1600-0846.2012.00612.x     Document Type: Article

References (30)

1. Castro SV, Jimenej SA. Biomarkers in SSc. Biomark Med 2010; 4(1): 133-147.
2. Akesson A, Hesselstrand R, Scheja A, Wildt M. Longitudinal development of skin involvement and reliability of high frequency ultrasound in systemic sclerosis. Ann Rheum Dis 2004; 63: 791-796.
3. Rodnan GP, Lipinski E, Luksick J. Skin thickness and collagen content in progressive systemic sclerosis and localized scleroderma. Arthritis Rheum 1979; 22: 130-140.
4. Furst DE, Clements PJ, Steen VD et al. The modified Rodnan skin score is an accurate reflection of skin biopsy thickness in systems sclerosis. J Rheumatol 1998; 25: 84-88.
5. Steen VD, Medsger TA. Improvement in skin thickening in systemic sclerosis associated with improved survival. Arthritis Rheum 2001; 44: 2828-2835.
6. Czirjak L, Nagy Z, Aringer M et al. The EUSTAR model for teaching and implementing the modified Rodnan skin score in systemic sclerosis. Ann Rheum Dis 2007; 66: 966-969.
7. Hesselstrand R, Scheja A, Akesson A. Mortality and causes of death in a Swedish series of systemic sclerosis patients. Ann Rheum Dis 1998; 57: 682-686.
8. Serup L, Serup J, Hagdrup HK. Increased central cornea thickness in systemic sclerosis. Acta Ophthalmol (Copenh) 1984; 62(1): 69-74.
9. Seibold JR, McCloskey DA. Skin involvement as a relevant outcome measure in clinical trials of systemic sclerosis. Curr Opin Rheumatol 1997; 9: 571-575.
10. Akesson A, Forsberg L, Hederstrom E et al. Ultrasound examination of skin thickness in patients with progressive systemic sclerosis (scleroderma). Acta Radiol Diagn 1986; 27: 91-94.
11. Hesselstrand R, Scheja A, Wildt M et al. High frequency ultrasound of skin involvement in systemic sclerosis reflects edema, extension and severity in early disease. Rheumatology 2008; 47: 84-87.
12. Medsger TA Jr, Bombardieri S, Czirjak L et al. The assessment of the patient with systemic sclerosis. Assessment of disease severity and prognosis. Clin Exp Rheumatol 2008; 21: S42-S46.
13. Clements PJ, Lachenburck PA, Seibold JR. Inter-and intra-observer variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis. J Rheumatol 1995; 22: 1281.
14. Clements PJ, Wong WK, Hurwitz EL, et al. Correlates of the disability index of Health Assessment Questionnaire: a measure of functional impairment in systemic sclerosis. Arthritis Rheum 1999; 42: 2372-2380.
15. Leroy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TA Jr et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 1988; 15: 202-205.
16. Serup J. Ring size measurement of the digits in females suffering from generalized scleroderma (Acrosclerosis). A simple method to quantify skin and soft tissue affection. Dermatologica 1985; 171: 41-44.
17. Serup J. Quantification of acrosclerosis: measurement of skin thickness and skin-phalanx distance in females with 15 MHz pulsed ultrasound. Acta Dermatovenereol. 1984; 64: 35-40.
18. Michio H. Usefulness of cutaneous ultrasound apparatus in systemic sclerosis. Jpn J Dermatol. 2002; 112(12): 1585-1591.
19. Brocks K, Stender I, Karlsmark T et al. Ultrasonic measurement of skin thickness in patients with systemic sclerosis. Acta Derm Venereol 2000; 80(3): 59-60.
20. Krieg K, Takehara K, Karlsmark T. Skin disease: a cardinal feature of systemic sclerosis. Rheumatology 2009; 48(3): 14-18.
21. Smith EA, LeRoy EC. Systemic sclerosis. Etiology and pathogenesis. In:, 2nd edn Klippel JH, Dieppe PA, Arnet FC, Brooks PM, Canoso JJ, Carette T, Dequeker, Grahame R, Keat AC, Kimberly RP, Liang MH, Maini RN, de Putte LBA, Sergent JS, Zvaifler NJ, Buckwalter JA and Peterfy CG, eds. Text Book of Rheumatology London. Mosby 1998; 10: 1481-1492.
22. Di Trapani G, Pocchiari M, Massillo C, Albanese A, Tulli A. Peripheral neuropathy in the course of progressive systemic sclerosis: light and ultrastructural study. Ital J Neurol Sci 1982; 4: 341-348.
23. Kaloudi O, Bandinelli F, Filippucci E, Conforti ML et al. High frequency ultrasound measurement of digital dermal thickness in systemic sclerosis. Ann Rheum Dis 2010; 69: 1140-1143.
24. Serup J. Localized scleroderma (morphoea): thickness of sclerotic plaques as measured by 15 MHz pulsed ultrasound. Acta Dermatovenereol 1984; 3: 214-219.
25. Grattagliano V, Iannone F, Praino E, De Zio A, Riccardi MT, Carrozzo N, Covelli M, Maggi P, Lapadula G. Digital laser doppler flowmetry may discriminate "limited" from "diffuse" systemic sclerosis. Microvasc Res 2010; 80(2): 221-226.
26. Quillinan, Niamh P, Denton CP, Christopher P. Disease modifying treatment in systemic sclerosis: current status. Curr Opin Rheumatol 2009; 21(6): 636-641.
27. Takehara K. Treatment of early diffuse cutaneous systemic sclerosis patients in Japan by low-dose corticosteroids for skin involvement. Clin Exp Rheumatol. 2004; 22 (3 suppl. 33): S87-S89.
28. Akerkar SM, Bichile LS. Therapeutic options for systemic sclerosis. Indian J Dermatol Venereol Leprol 2004; 70(2): 67-75.
29. Varga J. Systemic sclerosis. Epidemiology, pathology and pathogenesis. In: Primer on the rheumatic diseases 13th edition Klipple JH, Crofford LJ and White PH, eds. Springer Science + Business Media, LLC, New York 2008; 17: 351.
30. Toritsugi M, Yamamoto T, Nishioka K. Nodular cystic fat necrosis with systemic sclerosis. Eur J Dermatol 2004; 15(5): 353-355.